Exploring the relation of active surveillance schedules and prostate cancer mortality.
Zhenwei YangEveline A M HeijnsdijkLisa F NewcombDimitris RizopoulosNicole S ErlerPublished in: Cancer medicine (2024)
The detection delay is confirmed as a surrogate for prostate cancer mortality. A cut-off for a "safe" detection delay could not be identified.